Wisconsin Collaborative for Quality Healthcare

View Our Reports

print this page

Ischemic Vascular Disease: Statin Use Unless Contraindicated This is a measure developed by the Wisconsin Collaborative for Healthcare Quality (WCHQ).

Your Search Results: 31 Clinics in the Prevea Health health system


The results below represent the care of 2,413 patients with coronary and other atherosclerotic vascular disease. Read More About This Measure

Reporting Period:

Sort By Rank | Sort By Name  
Btn Export
Prevea Health - Allouez
N=220
95.91 %
View Historical Data
Prevea Health - Arcadia

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Ashwaubenon
N=228
94.74 %
View Historical Data
Prevea Health - Chippewa Falls

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Cornell

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - East DePere
N=426
91.78 %
View Historical Data
Prevea Health - East Mason
N=323
91.95 %
View Historical Data
Prevea Health - Eau Claire

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Gillett

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Howard
N=508
94.69 %
View Historical Data
Prevea Health - HWC

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Kewaunee

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Lena

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Luxemburg

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Marinette

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Menomonie

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Mountain

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Oconto
N=120
95.00 %
View Historical Data
Prevea Health - Oconto Falls

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - On-Site Clinic

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Osseo

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Plymouth

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Pulaski
N=124
84.68 %
View Historical Data
Prevea Health - Seymour

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Shawano Avenue

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Sheboygan

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - St. Mary's
N=281
97.15 %
View Historical Data
Prevea Health - St. Vincent

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Vernon Dr.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - Washington St.

The number of patients or providers is too small for
purposes of reliably reporting performance
Prevea Health - West DePere
N=183
90.16 %
View Historical Data

The American College of Cardiology (ACC) and the American Heart Association (AHA) recommends that high-intensity statin therapy should be initiated or continued as first-line therapy in women and men less than or equal to 75 years of age who have clinical atherosclerotic cardiovascular disease, unless contraindicated.

In November 2013, the ACC and AHA Task Force on Practice Guidelines released updated guidance for the treatment of blood cholesterol. The new recommendations remove treatment targets for LDL-C for the primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and recommend high or moderate intensity statin therapy based on patient risk factors. Four major statin benefit groups were identified and iIndividuals with ASCVD are one of the identified groups.


Disclaimer: Measures reported by WCHQ healthcare organizations represent a specific aspect of care in relation to an evidence-based standard, but are not clinical guidelines and do not establish standards of care.